We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
(+4.1%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$182M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$170M |
| 3 |
AET
Aetna Inc
AET
|
+$131M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$108M |
| 5 |
Brookdale Senior Living
BKD
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$435M |
| 2 |
Elevance Health
ELV
|
+$121M |
| 3 |
Cigna
CI
|
+$119M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$82.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.34% |
| 2 | Financials | 7.86% |
| 3 | Consumer Discretionary | 7.17% |
| 4 | Technology | 6.32% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Harley-Davidson
HOG
$2.58B
| $500K | 0.01% |
+8,874
| New | +$507K |
|
|
JCP
627
PUT
DELISTED
J.C. Penney Company, Inc.
JCP
| $500K | 0.01% |
+20,000
| New | +$173K |
|
|
KERX
628
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $499K | 0.01% |
50,000
+32,620
| +188% | +$350K |
|
629
Mondelez International
MDLZ
$79.5B
| $497K | 0.01% |
12,073
+3,812
| +46% | +$149K |
|
630
Netflix
NFLX
$299B
| $493K | 0.01% |
52,500
-600,320
| -92% | -$5.02M |
|
631
MidCap Financial Investment
MFIC
$787M
| $492K | 0.01% |
23,166
-3,231
| -12% | -$74.8K |
|
|
CYOU
632
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $490K | 0.01% |
16,416
-25,477
| -61% | -$785K |
|
|
INSY
633
DELISTED
Insys Therapeutics, Inc.
INSY
| $490K | 0.01% |
+13,653
| New | +$425K |
|
634
Johnson & Johnson
JNJ
$618B
| $488K | 0.01% |
+5,012
| New | +$502K |
|
|
PAY
635
DELISTED
Verifone Systems Inc
PAY
| $485K | 0.01% |
+14,292
| New | +$518K |
|
636
Franklin Electric
FELE
$4.63B
| $483K | 0.01% |
+14,935
| New | +$536K |
|
|
PGN
637
DELISTED
PARAGON OFFSHORE PLC (GBR)
PGN
| $480K | 0.01% |
439,607
-33,868
| -7% | -$55K |
|
638
Jefferies Financial Group
JEF
$12.6B
| $478K | 0.01% |
21,971
-14,254
| -39% | -$304K |
|
|
VIAB
639
DELISTED
Viacom Inc. Class B
VIAB
| $478K | 0.01% |
7,400
+4,300
| +139% | +$291K |
|
|
DYN
640
DELISTED
Dynegy, Inc.
DYN
| $478K | 0.01% |
+16,338
| New | +$531K |
|
641
Mattel
MAT
$4.38B
| $475K | 0.01% |
18,484
-21,797
| -54% | -$574K |
|
642
O-I Glass
OI
$1.1B
| $474K | 0.01% |
20,651
-173,161
| -89% | -$4.21M |
|
|
AMTD
643
DELISTED
TD Ameritrade Holding Corp
AMTD
| $471K | 0.01% |
12,795
+2,353
| +23% | +$87.4K |
|
644
Avery Dennison
AVY
$13B
| $469K | 0.01% |
7,694
+3,132
| +69% | +$182K |
|
|
WNR
645
DELISTED
Western Refining Inc
WNR
| $468K | 0.01% |
+10,733
| New | +$477K |
|
646
SS&C Technologies
SSNC
$18.1B
| $467K | 0.01% |
+14,938
| New | +$458K |
|
647
Dillards
DDS
$9.19B
| $464K | 0.01% |
+4,410
| New | +$541K |
|
|
AAWW
648
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $463K | 0.01% |
+8,419
| New | +$435K |
|
649
Popular Inc
BPOP
$11.2B
| $462K | 0.01% |
16,006
-1,803
| -10% | -$60.6K |
|
650
Genworth Financial
GNW
$3.76B
| $460K | 0.01% |
60,766
+49,966
| +463% | +$399K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
- Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
- Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
- Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
- Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
- Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
- Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.
Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.